News Archive
Granting of patent
Eden Research plc, a leading UK agrochemical development company, is pleased to announce it has been granted a patent covering the use of terpenes in treating plant diseases. This is a further milestone in Eden's continuing drive to secure a proprietary position in relation to developing novel plant treatments.
South African patent number ZA2004/2367 is the first in a family of applications to be granted. Corresponding applications are proceeding in Europe, the United States, New Zealand, Australia, Mexico and Brazil.
In this case, the patent will apply to treatments with particular significance to the wine industry, but will also have more universal applications in the future.
Tim Griffiths, Chief Executive, Eden Research plc said:
"This is great news for Eden and takes us one step closer towards achieving commercialisation for our development portfolio."
For further information:
| Tim Griffiths, Chief Executive | Eden Research plc | Tel: 01993 868844 |
| Jonathon Brill /Caroline Stewart | Financial Dynamics | Tel: 020 7831 3113 |
Notes to editors
About Eden Research plc
Eden Research plc is a UK-registered company traded on Ofex and specialising in agrochemical solutions for business through the application of an intellectual property bank and licensing projects.
In particular, Eden focuses on developing natural solutions and products for the agricultural sector through the application of terpene-based chemistry and other environmentally friendly technologies.
Terpenes are naturally occurring, low-toxicity botanical substances often produced by plants as part of their defence mechanisms. Working closely with several major universities and international research organisations, Eden develops products for licensing on to major companies for agricultural application as a pesticide and in the treatment of plant infections, soil infestations and post-harvest treatments.
The Directors of Eden Research plc accept responsibility for this announcement.